Children with Type 1 diabetes are up to ten times more likely to develop celiac disease than children in the general population. A new piece from Celiac.com makes the case for routine celiac screening in that population — and what makes the argument compelling is that most of these children show no obvious symptoms. They won’t complain about their stomach. They may look and feel fine. Without a blood test, their celiac disease goes undetected — and that silent damage quietly undermines their diabetes care.
What This Means for T1D Families
Both Type 1 diabetes (T1D) and celiac disease are autoimmune conditions. In T1D, the immune system attacks insulin-producing cells in the pancreas. In celiac disease, it attacks the lining of the small intestine whenever gluten is present. Because both conditions share the same underlying genetic risk factors, a child who develops one is at elevated risk for the other.
That risk is not small. Studies consistently put celiac prevalence in children with T1D at 3–10%, compared to roughly 1% in the general population. In a room of twenty T1D kids, one or two are likely living with undiagnosed celiac. And because celiac often causes no noticeable GI symptoms in this group, those children won’t come forward on their own — and their families won’t know to ask.
Here’s what makes that gap clinically significant: celiac disease damages the small intestine in a way that disrupts nutrient absorption, including how carbohydrates are absorbed after meals. For a child already working to maintain stable blood glucose, that unpredictability is a serious problem. Families who feel like they are doing everything right and still can’t get consistent readings may be dealing with undetected celiac. A diagnosis and a gluten-free diet can change that picture.
The American Diabetes Association recommends screening T1D patients for celiac at diagnosis, again at one and two years after diagnosis, and every five years beyond that. Many clinics follow this. Many don’t. As parents, the clearest thing we can do is ask — directly — at the next diabetes appointment whether celiac screening has been done, and if not, why not.
Key Takeaways
- Children with Type 1 diabetes are 5–10 times more likely than average to develop celiac disease.
- Most T1D children with celiac have no obvious stomach symptoms — a blood test is the only reliable way to find it.
- Undiagnosed celiac disrupts carbohydrate absorption and can destabilize blood sugar control, making T1D harder to manage.
- The American Diabetes Association recommends celiac screening at T1D diagnosis and at regular intervals afterward.
- A blood test (tTG-IgA) is the standard first screen — non-invasive, widely available, and covered by most insurance.
- Celiac disease can develop years after an initial negative screen, so one normal result doesn’t end the conversation.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
Why These Two Conditions Share Genetic Ground
The link between T1D and celiac disease starts in the HLA system — Human Leukocyte Antigen, a set of proteins on cell surfaces that help the immune system tell “self” from “threat.” Certain HLA variants, specifically HLA-DQ2 and HLA-DQ8, dramatically raise the risk of developing both T1D and celiac disease. A child who inherits these variants is genetically primed for autoimmune responses targeting multiple tissues — not just one.
This shared genetic architecture explains why the two conditions cluster together. It also explains why a child diagnosed with T1D should be considered at elevated risk for celiac from day one, not just if symptoms appear later.
We covered the diagnostic complexity this overlap creates in our earlier piece on the challenge of diagnosing celiac disease in pediatric T1D, which documents how long-term serological surveillance often catches cases that a one-time screen would miss.
Why Silent Celiac Is Especially Common in T1D
Subclinical or silent celiac describes a case where intestinal damage is confirmed on biopsy, but classical gastrointestinal symptoms — diarrhea, bloating, obvious pain — are absent or mild. This presentation is disproportionately common in children with T1D, for reasons researchers are still working to clarify.
One leading explanation involves dietary patterns. Children on tightly managed T1D diets often eat fewer refined carbohydrates, which means less gluten overall — not enough to eliminate the immune response, but potentially enough to suppress the most visible GI symptoms. The immune reaction continues below the surface. So does the intestinal damage.
That damage is called villous atrophy — the flattening of the tiny finger-like projections (villi) that line the small intestine and drive nutrient absorption. Even without obvious symptoms, a child with active villous atrophy absorbs carbohydrates inconsistently. The result shows up as erratic post-meal glucose spikes and unexpected hypoglycemia (low blood sugar episodes) that complicate insulin management.
What Screening Looks Like in Practice
The standard first-line screen is the tTG-IgA test — tissue transglutaminase IgA antibody, an immune marker the body produces in response to a protein involved in processing gluten. A positive result triggers follow-up: either an EMA-IgA (endomysial antibody) confirmatory test, or a direct referral for upper endoscopy with duodenal biopsy, which remains the diagnostic gold standard.
One important caveat: the tTG-IgA test requires the child to be consuming gluten regularly to produce a detectable immune response. A child who has already reduced gluten — intentionally or as a side effect of a low-carb T1D diet — may test negative even with active celiac disease. Families should flag any dietary changes to the gastroenterologist before testing begins.
The ADA’s recommended schedule is: screen at T1D diagnosis, repeat at one year and two years post-diagnosis, and every five years after that if results remain negative. The rationale for ongoing screening is important: celiac disease can develop months or years after a T1D diagnosis, even in children who were negative initially. The autoimmune risk doesn’t resolve with one clean result.
What Changes After Diagnosis
Research published in multiple cohorts — including a five-center European study and data reviewed in our prior coverage of pediatric celiac disease and coexisting immune-mediated conditions — shows that children with T1D who start the gluten-free diet after celiac diagnosis often see measurable improvement in HbA1c (glycated hemoglobin, the standard three-month average blood glucose marker). When the intestinal lining heals and absorption normalizes, blood sugar becomes more predictable. That’s a meaningful clinical benefit layered on top of the direct benefits of treating celiac disease itself.
Layering a gluten-free diet onto T1D management adds real complexity to an already demanding care plan. Celiac families know how hard label-reading and social navigation are on their own. Combine that with carb counting and insulin timing, and the burden on the child and family is substantial. I hold enormous respect for families managing both. But the alternative — leaving celiac undetected and watching blood glucose remain unstable — carries real long-term consequences: increased risk of complications, slower growth, bone density concerns from malabsorption of calcium and vitamin D.
The screening test is a blood draw. The information it provides can reshape how a family manages everything else.
Related Coverage
- Challenge of diagnosing celiac disease in pediatric Type 1 diabetes mellitus: lessons from long-term serological surveillance
- Pediatric celiac disease and coexisting immune-mediated conditions: a five-year single-center study from North-Eastern Romania
References
- Celiac.com. “Why Children With Type 1 Diabetes Should Be Screened for Celiac Disease.” Published July 18, 2026. Read the original article
- American Diabetes Association. Standards of Medical Care in Diabetes. Current guidelines recommend celiac antibody screening at diagnosis of T1D and periodically thereafter.
This article is for informational purposes only. Consult your child’s gastroenterologist or endocrinologist for guidance specific to your family’s situation.